已收盘
0.000
NaN.00%
Longevity Health Holdings shares surge on Tuesday afternoon. The stock gained after announcing a merger with plasma collector True Health.
2025-07-16 04:14
TTD: 16% | The Trade Desk Will Replace Ansys In The S&P 500 Effective Prior To The Opening Of Trading On Friday, July 18 XAGE: 106% | Longevity Health Executes Definitive Merger Agreement With True
2025-07-15 19:15
Longevity Health Holdings, Inc. (NASDAQ:XAGE), a company focused on human longevity and healthy aging ("Longevity", the "Company", "we", "our", or "us"), today announced the execution of a definitive merger agreement
2025-07-15 04:32
Longevity Health Holdings announced the execution of a definitive merger agreement with True Health Inc. (THPlasma) to combine the companies in an all-stock transaction. THPlasma, a leading player in the plasma collection industry, will merge with Longevity, which is focused on human longevity and healthy aging. The combined company will continue to trade on Nasdaq under the symbol “XAGE”. THPlasma has been rapidly expanding its plasma collect...
2025-07-14 20:30
Longevity Health Holdings ( ($XAGE) ) just unveiled an announcement. Longevity ...
2025-06-26 05:32
https://www.sec.gov/Archives/edgar/data/1842939/000095017025090015/xage-20250624.htm
2025-06-26 05:10
Agreement Expanded for Additional Five YearsPALM BEACH GARDENS, Fla., June 3, 2025 /PRNewswire/ -- Longevity Health, a clinical services company and national Institutional Special Needs Plan (ISNP), today announced that
2025-06-03 23:19
Longevity Health Holdings, Inc. (NASDAQ:XAGE) ("XAGE," the "Company," "we" or "our"), a company dedicated to advancing human longevity and healthy aging through regenerative bio-aesthetics, diagnostics, and nutrition,
2025-05-27 21:22
Longevity Health Holdings, Inc. (XAGE) successfully sold 479,621 shares of its common stock at an average price of $4.08 per share through its at-the-market (ATM) equity offering, raising approximately $1.96 million in gross proceeds. This financing extends XAGE’s cash runway into Q1 FY26, assuming no growth beyond its pro forma FY24 sales and not factoring in the planned merger with 20/20. XAGE CEO Rajiv Shukla expressed confidence in the merger...
2025-05-27 13:20
Longevity Health Holdings ( ($XAGE) ) has shared an update. On May 20, 2025, Lo...
2025-05-22 05:51